Example: Heart Attack

Clinical Trials on Respiratory Syncytial Virus Infections

Total 263 results

NCT02387606

Completed

Study to Evaluate Antiviral Activity, Safety, and Pharmacokinetics of Repeated Doses of Orally Administered JNJ 53718678 Against Respiratory Syncytial Virus Infection.

Conditions: Respiratory Syncytial Virus Infections
NCT03656510

Recruiting

Study to Evaluate Safety and Antiviral Activity of Doses of JNJ-53718678 in Children (>=28 Days to <=3 Years) With Respiratory Syncytial Virus Infection

Conditions: Respiratory Syncytial Virus Infections
NCT03332459

Completed

A Long-term Follow-up Study to Evaluate the Impact of Lumicitabine on the Incidence of Asthma and/or Wheezing in Infants and Children With a History of Respiratory Syncytial Virus Infection

Conditions: Respiratory Syncytial Virus Infections
NCT01297504

Completed

A One-Year Observation of Palivizumab in Infants at Risk for Respiratory Syncytial Virus Infection in Latin America

Conditions: Respiratory Syncytial Virus Infection
NCT04633187

Recruiting

Effects of EDP-938 in Adult Hematopoietic Cell Transplant Recipients Who Are Infected With Acute Respiratory Syncytial Virus (RSV) of the Upper Respiratory Tract

Conditions: Respiratory Syncytial Virus Infections
NCT04056611

Recruiting

Effects of JNJ-53718678 in Adult and Adolescent Participants Who Had a Hematopoietic Stem Cell Transplantation and Who Are Infected With Respiratory Syncytial Virus (RSV)

Conditions: Respiratory Syncytial Virus Infections
NCT01349543

Completed

The Development of a Human Model of Respiratory Syncytial Virus Infection

Conditions: Respiratory Syncytial Virus Infections; Respiratory Viral Infections
NCT01107535

Completed

Effectiveness of Synagis (Palivizumab) Immunoprophylaxis in Preterm Infants With High Risk of Severe Respiratory Syncytial Virus (RSV) Infection

Conditions: Respiratory Syncytial Virus Infection
NCT03715023

Terminated

Anti-viral Effect of PC786 on RSV Infection on HSCT Recipients

Conditions: Respiratory Syncytial Virus Infections
NCT01754428

Completed

Surveillance Study of Respiratory Syncytial Virus Infection (RSV) in Subjects < 24 Months of Age

Conditions: Respiratory Syncytial Virus Infections
NCT00192504

Completed

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of a Single Intravenous Dose of MEDI-524, a Humanized Enhanced Potency Monoclonal Antibody to Respiratory Syncytial Virus (RSV), in Otherwise Healthy Children Hospitalized With RSV Infection

Conditions: Respiratory Syncytial Virus Infections
NCT04231968

Not yet recruiting

A Study of AK0529 in Chinese Infants Hospitalized With RSV

Conditions: Respiratory Syncytial Virus Infections
NCT03699202

Recruiting

Anti-RSV Study in Chinese Patients (ASCENT)

Conditions: Respiratory Syncytial Virus Infections
NCT03258502

Completed

Safety, Pharmacokinetics and Antiviral Activity of RV521 Against RSV

Conditions: Respiratory Syncytial Virus Infections
NCT02654171

Completed

Viral Inhibition in Children for Treatment of RSV

Conditions: RESPIRATORY SYNCYTIAL VIRUS INFECTIONS
NCT02094365

Completed

A Phase 2a Study to Evaluate ALS-008176 in the Virus Challenge Model

Conditions: Respiratory Syncytial Virus Infections
NCT02460016

Terminated

A Study of AK0529 in Infants Hospitalized With RSV

Conditions: Respiratory Syncytial Virus Infections
NCT04491877

Recruiting

Study of a Live-Attenuated Respiratory Syncytial Virus Vaccine in Infants and Toddlers

Conditions: Respiratory Syncytial Virus Infection
NCT04444284

Active, not recruiting

Study of the Safety and Immunogenicity of an Intranasal Vaccine for Respiratory Syncytial Virus in Seropositive Children

Conditions: Respiratory Syncytial Virus Infections
NCT04227210

Completed

Safety and Immune Response to an Investigational Vaccine Against Respiratory Syncytial Virus in Healthy Adults

Conditions: Respiratory Syncytial Virus Infections
NCT03814590

Completed

A Study to Assess the Safety, Reactogenicity and Immune Response of GlaxoSmithKline (GSK) Biologicals' Investigational Respiratory Syncytial Virus (RSV) Vaccine (GSK3844766A) in Older Adults

Conditions: Respiratory Syncytial Virus Infections
NCT04090658

Active, not recruiting

A Study to Test GlaxoSmithKline's (GSK) Respiratory Syncytial Virus RSV Candidate Vaccine's Safety and Immune Response in Japanese Older Adults

Conditions: Respiratory Syncytial Virus Infections
NCT03624790

Active, not recruiting

Inpatient Challenge Study of rRSV A/Maryland/001/11, a Human Respiratory Syncytial Virus Challenge Strain, Administered to Healthy Adult Volunteers

Conditions: Respiratory Syncytial Virus Infections
NCT03422237

Active, not recruiting

Evaluating the Infectivity, Safety, and Immunogenicity of the Recombinant Live-Attenuated Respiratory Syncytial Virus (RSV) Vaccines RSV ΔNS2/Δ1313/I1314L or RSV 276 in RSV-Seronegative Infants and Children 6 to 24 Months of Age

Conditions: Respiratory Syncytial Virus Infections
NCT03379675

Completed

A Study to Explore the Antiviral Activity, Clinical Outcomes, Safety, Tolerability, and Pharmacokinetics of JNJ-53718678 at Two Dose Levels in Non-Hospitalized Adult Participants Infected With Respiratory Syncytial Virus

Conditions: Respiratory Syncytial Virus Infections